(Q36669477)

15 August 2017

1 reference

title

Factors associated with outcomes of acute exacerbations of chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

15 August 2017

main subject

1 reference

Wan C Tan

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

15 August 2017

published in

1 reference

15 August 2017

volume

1

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

225-247

1 reference

Survival and quality of life: short-term versus long-term ventilator patients.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Mortality after hospitalization for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Economic analysis of the Confronting COPD survey: an overview of results

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

The economic burden of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Pharmacoeconomic evaluation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

The costs of exacerbations in chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

An economic overview of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Clinical research in chronic obstructive pulmonary disease: needs and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immuno

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Toward a consensus definition for COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Chronic mucus hypersecretion in COPD and death from pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Predicting non-elective hospital readmissions: a multi-site study. Department of Veterans Affairs Cooperative Study Group on Primary Care and Readmissions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Review of the prescription of domiciliary long term oxygen therapy in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Long-term oxygen therapy at home. Compliance with medical prescription and effective use of therapy. ANTADIR Working Group on Oxygen Therapy. Association Nationale de Traitement à Domicile des Insuffisants Respiratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Health effects of passive smoking. 8. Passive smoking and risk of adult asthma and COPD: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Confounding by indication: an example of variation in the use of epidemiologic terminology

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

The role of infection in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Infectious etiology of acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Role of infection in chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Bacterial infection in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Do bacteria cause exacerbations of COPD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

The role of bacteria in exacerbations of COPD. A constructive view

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Interactions between Viruses and Bacteria in Patients with Chronic Bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Variables associated with changes in spirometry in patients with obstructive lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

The natural history of chronic airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Predictors of survival in subjects with chronic airflow limitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Nutritional status and mortality in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Nutritional support for individuals with COPD: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Current thoughts regarding treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Inhaled corticosteroids and hospitalisation due to exacerbation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Contemporary management of chronic obstructive pulmonary disease: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

"Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Patients' and carers' preferences in two models of care for acute exacerbations of COPD: results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

Vital prognosis after hospitalization for COPD: A study of a random population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

The burden of asthma and chronic obstructive pulmonary disease: data from The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-120039210

21 January 2018

Identifiers

DOI

10.1081/COPD-120039210

1 reference

15 August 2017

1 reference